Captura Biopharma - Crunchbase Company Profile & Funding

Q: When was the last funding round for Captura Biopharma?

Captura Biopharma closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Captura Biopharma raised to date?

Captura Biopharma has raised obfuscated.

Overview

Captura Biopharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Captura Biopharma

CB Rank

66431

Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.

Founded

obfuscation

Private

Venture - Series Unknown

Little Rock, Arkansas, United States

1-10

www.capturabiopharma.com/

Biopharma

Biotechnology

Life Science

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Anthony Soscia: President, Co-Founder
Michael Geranen: Chief Executive Officer
Past Role: Ezra Innovations, Founder & CEO

Details

Legal Name

Captura Biopharma, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Anthony Soscia, Michael Geranen

About the Company

Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide contamination and heavy metal poisoning. Its lead chelation candidate, C2E2, will be the world's first oral treatment indicated for internal radiation contamination and has

been proven in efficacy studies to target select heavy metals, notably americium, plutonium, and lead. Heavy metal contamination, including exposure to transuranic elements, is on the rise.

Phone Number

501-516-3905

Contact Email

michael@capturabiopharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Captura Biopharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

C2E2

An oral drug candidate designed to bind and eliminate radioactive heavy metals and toxic metals from the body.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Captura Biopharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
The Global Emerging Markets Group	Yes	Venture Round - Captura Biopharma	—
The Global Emerging Markets Group	Yes	Venture Round - Captura Biopharma	—
The Global Emerging Markets Group	Yes	Venture Round - Captura Biopharma	—
The Global Emerging Markets Group	Yes	Venture Round - Captura Biopharma	—
The Global Emerging Markets Group	Yes	Venture Round - Captura Biopharma	—